Edition:
United Kingdom

GTX Inc (GTXI.OQ)

GTXI.OQ on NASDAQ Stock Exchange Capital Market

1.24USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
262,026
52-wk High
$25.60
52-wk Low
$1.22

Chart for

About

GTx, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs). Its... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $131.52
Shares Outstanding(Mil.): 16.06
Dividend: --
Yield (%): --

Financials

  GTXI.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.71 -- --
ROI: -196.34 9.01 14.96
ROE: -196.34 10.15 16.52

Earnings vs. Estimates